Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls30_0033.txt
Page: 0033
Total Pages: 34

Subject: MEDICAL BIOLOGIC WARFARE DEFENSE                                

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES                                            

Document Number:          1

Folder Seq  #:        246









        SGPS-ZA
        SUBJECT: Vaccine Policy Recommendation


        production estimates, timely Food and Drug Administration action,
        a force turn-over rate of 15 percent and following vaccination
        regimen: Anthrax - five shots and an annual booster; Botulinum
        Toxoid - three shots and an annual booster.

                 (3) (U) Enclosed is a packet of charts detailing
        national production capabilities.

        4. (S)   Recommendations:

             a.  (U) Establish as U.S. policy that SMs will be
        vaccinated against Biological Warfare (BW) agents during
        peacetime.

             b. (U) Establish criteria (broad enough to cover future
        agents) governing BW vaccination procedures.

             c.       Anthrax vaccine.

                           Use the stocks on hand. Begin vaccinating


                 (2)       Future production is reasonably certain. An
        unvaccinated force encourages use of this agent against U.S.
        forces. Give boosters to soldiers already vaccinated.

             d.       Botulinum Toxoid.

                 (1)       Vaccinate enough units so that it is perceived
        that U.S. soldiers are protected.

                 (2)                                              At a
        minimum, vaccinate all soldiers assigned in geographic areas
        where countries with active/suspected BW programs exist.

                 (3)       If started now, a vaccinated force of
        could be established and maintained@mo@@@@@@l.@To
        better until we are able to increase our production base, i.e., a
        dedicated production facility.

             e. (U) Build a BW vaccine production facility.

        5.       In short, the military and civilian medical community






                                        2

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 34 f:/Week-36/BX003203/MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES/medical biologic warfare defense:12179609282531
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES
Folder Seq # = 246
Subject = MEDICAL BIOLOGIC WARFARE DEFENSE
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996